Previous 10 | Next 10 |
2024-04-06 20:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
JERUSALEM and BURLINGTON, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced results published in ...
JERUSALEM and BURLINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced positive results in a...
BURLINGTON, Mass. and JERUSALEM, March 18, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced today that its signif...
2024-03-06 23:19:04 ET Summary BrainsWay reported strong growth and a small profit in the fourth quarter of 2023. The company also gave strong guidance for 2024. Recent strength internationally and amongst larger customers is expected to persist. In addition, the commercialization...
2024-03-06 10:04:09 ET BrainsWay Ltd. (BWAY) Q4 2023 Earnings Conference Call March 06, 2024 08:30 A.M. ET Company Participants Troy Williams - IR, LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Participants Jeffrey Cohen - Ladenbur...
2024-03-06 08:45:57 ET More on Mid-day gainers & stocks. Dada Nexus Rides Closer To JD.com's Orbit With Management Shakeup Infobird to effect 1-for-8 reverse stock split to regain compliance with Nasdaq rules NIO, Dada Nexus and Luckin Coffee lead strong recovery...
2024-03-06 07:40:10 ET More on Brainsway BrainsWay Q4 Earnings Preview BrainsWay Is Reviving From A Deep Depression Seeking Alpha’s Quant Rating on Brainsway Historical earnings data for Brainsway Financial information for Brainsway R...
Generated Record Revenues with Robust 50% Year-over-Year Revenue Growth in Q4 2023; Generated Positive Quarterly Net Income Providing Full-Year 2024 Revenue Guidance of $ 3 7 -$ 4 0 M illion with Continued Profitability Momentum and Ca...
Klepierre (KLPEF) is expected to report for Q4 2023 comScore Inc. (SCOR) is expected to report $0.8 for Q4 2023 Universal Stainless & Alloy Products Inc. (USAP) is expected to report for Q4 2023 FAT Brands Inc. (FAT) is expected to report $-1.55 for Q4 2023 Jet.AI Inc. (JTAI) ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-16 23:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BURLINGTON, Mass. and JERUSALEM, June 17, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its broad market...